Loading...
Loading...
Deep dives into optimization research, compound studies, and evidence-based protocols.
From semaglutide to retatrutide to oral formulations and combination therapies — mapping the entire GLP-1 pipeline and what it means for metabolic optimization.
Creatine isn't just for muscles. A growing body of evidence shows it enhances working memory, reduces mental fatigue, and provides neuroprotection — especially for vegetarians and the sleep-deprived.
A tiered supplement framework organized by age decade — from foundational essentials in your 20s to advanced interventions in your 60s+.
A critical review of adaptogens ranked by clinical evidence — separating Rhodiola and Ashwagandha's strong data from the marketing hype surrounding lesser-studied herbs.
A head-to-head comparison of the four leading mitochondrial interventions — each targeting a different aspect of mitochondrial health.
Why the discovery of a dedicated human transporter for this fungal amino acid has researchers reclassifying it as essential — and what the epidemiological data shows.
A data-driven comparison of the two leading GLP-1 drugs, analyzing the clinical trial evidence for weight loss, metabolic outcomes, and side effect profiles.
A step-by-step framework for choosing your first peptide based on your primary goal — healing, body composition, cognitive enhancement, immune support, or anti-aging.
A dispassionate look at the cognitive enhancement evidence for pure nicotine — what dozens of clinical trials actually show, proper dosing, and honest assessment of addiction risk.
Why magnesium deficiency is epidemic, how it affects brain function, sleep, and longevity — and why L-Threonate is the form that matters most for cognitive optimization.
Exploring how BPC-157, KPV, and other peptides modulate the gut-brain axis — and why gut health might be the most underrated factor in cognitive performance.
An exploration of senolytic therapy — from the Mayo Clinic's groundbreaking fisetin research to the first human clinical trials targeting cellular senescence.
A head-to-head comparison of the two leading NAD+ precursors based on current clinical evidence, bioavailability data, and practical considerations.
A deep dive into the 100+ preclinical studies on BPC-157, examining its mechanisms, efficacy across tissue types, and the path toward human clinical trials.